Agilent, Celera Stocks Upgraded

Agilent's shares soared along with the broader market on Monday, while Celera's stock dropped. Even though an analyst upgraded the stock, he also lowered his revenues and EPS estimates for the firm.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.